The study, titled “GenAI-Powered Framework for Reliable Sentiment Labeling in Drug Safety Monitoring,” published in Applied ...
Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Natural product libraries enable the discovery of bioactive compounds through diverse screening workflows. Inherent ...
Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...
Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...
Explore how medical robots and healthcare robotics enhance surgery, diagnostics, and hospital workflows, highlighting key ...
Ebenbuild GmbH, a Munich-based deep-tech healthcare company, today announced the publication of a peer-reviewed ...
An analysis has found that anti-amyloid drugs, once hailed as a breakthrough in Alzheimer's treatment, have low clinical ...
A groundbreaking research project led by the Department of Pharmacy and Biotechnology at the University of Bologna is aiming ...
Boston Micro Fabrication unveils BMF Clear resin, achieving true optical transparency in micro-precision 3D printing ...
Explore why Yuri Milner keeps funding research at the intersection of AI and biology, enhancing our understanding of genetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results